WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announced today the availability of a new brief regarding the impact of COVID-19 on telehealth.
The brief, based on a survey of 561 healthcare providers (HCPs) in the U.S., finds that 46 percent of healthcare providers across a wide range of specialties are using more telemedicine than before COVID-19. Radiologists, psychiatrists and cardiologists are leading the charge in providing telemedicine, but many other specialties are also getting on board.
“For most physicians, practices and life sciences companies, telehealth is still uncharted territory,” said Neal Dunn, Senior Partner, Head of Insights and Analytics, Trinity Life Sciences. “Trinity is a resource to help life sciences companies define the “new normal” for field sales forces, capture insights through market research and forecast the impact these changes have on brands.”
For access to the brief, please visit COVID-19 Briefing Series: Telehealth as the New Normal? How COVID-19 is Shifting the Patient Journey.
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
